SCHEMBL1013201

SCHEMBL1013201

NC(=O)OC(=O)N(c1ccccc1)C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ATM Q13315 1/20 0.37
NPSR1 Q6W5P4 4/20 0.35
ALDH1A1 P00352 2/20 0.33
CES1 P23141 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
RAB9A P51151 2/20 0.33
CYP3A4 P08684 2/20 0.32
CYP2C19 P33261 2/20 0.32
MAPT P10636 2/20 0.32
POLB P06746 1/20 0.32
PARP1 P09874 1/20 0.32
TSHR P16473 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NR1H3 Q13133 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1067570 0.80 NPSR1 (0.41) TDP1L3MBTL1NPSR1ALDH1A1CES1
Carbamic Acid SCHEMBL1013200 0.78 NPSR1 (0.40) TDP1L3MBTL1NPSR1ALDH1A1CES1
SCHEMBL5559017 0.76 MEN1 (0.39) TDP1L3MBTL1ATMNPSR1ALDH1A1
SCHEMBL2249329 0.76 L3MBTL1 (0.57) TDP1L3MBTL1ATMNPSR1ALDH1A1
SCHEMBL1008397 0.75 NPSR1 (0.44) TDP1L3MBTL1ATMNPSR1ALDH1A1
SCHEMBL28188463 0.75 ALDH1A1 (0.49) L3MBTL1NPSR1ALDH1A1CES1KMT2A
SCHEMBL9335045 0.75 HTT (0.46) TDP1L3MBTL1ATMNPSR1ALDH1A1
SCHEMBL9505610 0.74 NPSR1 (0.40) L3MBTL1NPSR1ALDH1A1CES1KMT2A
SCHEMBL3938034 0.74 NPSR1 (0.43) TDP1L3MBTL1ATMNPSR1ALDH1A1
SCHEMBL27645265 0.72 CHRNB2 (0.38) TDP1L3MBTL1ATMNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 EP disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed